AIRLINK 70.55 Decreased By ▼ -2.51 (-3.44%)
BOP 4.99 Decreased By ▼ -0.10 (-1.96%)
CNERGY 4.33 Decreased By ▼ -0.04 (-0.92%)
DFML 31.48 Decreased By ▼ -0.97 (-2.99%)
DGKC 77.00 Increased By ▲ 1.51 (2%)
FCCL 20.00 Increased By ▲ 0.48 (2.46%)
FFBL 35.11 Decreased By ▼ -1.04 (-2.88%)
FFL 9.19 Decreased By ▼ -0.03 (-0.33%)
GGL 9.91 Increased By ▲ 0.06 (0.61%)
HBL 113.70 Decreased By ▼ -3.00 (-2.57%)
HUBC 133.17 Increased By ▲ 0.48 (0.36%)
HUMNL 7.10 No Change ▼ 0.00 (0%)
KEL 4.35 Decreased By ▼ -0.06 (-1.36%)
KOSM 4.33 Decreased By ▼ -0.07 (-1.59%)
MLCF 36.83 Increased By ▲ 0.63 (1.74%)
OGDC 133.35 Decreased By ▼ -0.15 (-0.11%)
PAEL 22.50 Decreased By ▼ -0.10 (-0.44%)
PIAA 24.80 Decreased By ▼ -1.21 (-4.65%)
PIBTL 6.51 Decreased By ▼ -0.04 (-0.61%)
PPL 117.62 Increased By ▲ 2.31 (2%)
PRL 26.39 Decreased By ▼ -0.24 (-0.9%)
PTC 13.83 Decreased By ▼ -0.27 (-1.91%)
SEARL 52.73 Decreased By ▼ -0.72 (-1.35%)
SNGP 69.20 Increased By ▲ 1.95 (2.9%)
SSGC 10.70 No Change ▼ 0.00 (0%)
TELE 8.42 No Change ▼ 0.00 (0%)
TPLP 10.92 Increased By ▲ 0.17 (1.58%)
TRG 60.14 Decreased By ▼ -3.73 (-5.84%)
UNITY 25.15 Increased By ▲ 0.03 (0.12%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 7,452 Decreased By -9.5 (-0.13%)
BR30 24,147 Decreased By -24.3 (-0.1%)
KSE100 71,143 Increased By 40.9 (0.06%)
KSE30 23,395 Increased By 0.4 (0%)
World

EU drugs agency meeting to discuss Moderna COVID-19 vaccine

  • The EMA's human medicines committee (CHMP) had been scheduled to meet on Wednesday.
  • In the event that the CHMP reaches an opinion at today's meeting, we would send out a press release as soon as possible after the meeting,
Published January 4, 2021

AMSTERDAM: The European Medicines Agency (EMA) was holding a meeting on Monday, two days ahead of schedule, that could decide to recommend approving Moderna's COVID-19 vaccine, a spokesperson said.

The EMA's human medicines committee (CHMP) had been scheduled to meet on Wednesday.

The agency has set a Jan. 12 deadline for whether to recommend Moderna's vaccine. It recommended a COVID-19 vaccine from Pfizer and its German partner BioNTech on Dec. 21.

"In the event that the CHMP reaches an opinion at today's meeting, we would send out a press release as soon as possible after the meeting," it said in a statement.

A CHMP meeting scheduled for Wednesday was still planned "in case the committee does not reach a decision today," it added.

Comments

Comments are closed.